The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review

Denosumab is a potent anti-resorptive medication used to treat patients at high risk for osteoporosis; however, its beneficial effects on the skeletal system are quickly reversed after discontinuation. In contrast, bisphosphonates (BPs) are anti-resorptive agents with residual effects on the bone ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Inojosa, Arthur Costa, Mendes, Laís, Bandeira, Leonardo, Bandeira, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760774/
https://www.ncbi.nlm.nih.gov/pubmed/36529864
http://dx.doi.org/10.11005/jbm.2022.29.4.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760774/
https://www.ncbi.nlm.nih.gov/pubmed/36529864
http://dx.doi.org/10.11005/jbm.2022.29.4.217

Ejemplares similares